Evaluating the Efficacy of a Pre-Established Lipid-Lowering Algorithm in Managing Hypercholesterolemia in Patients at...

Area of Science:

• Cardiology
• Pharmacology
• Preventive Medicine

Background:

• European studies show suboptimal LDL-C target achievement in very high-risk cardiovascular patients.
• Combination therapy with statins and ezetimibe is underutilized.

Purpose of the Study:

• To assess a lipid-lowering algorithm's effectiveness in reaching LDL-C targets.
• Focus on very high-risk patients one month and one year post-hospitalization.

Main Methods:

• Single-center study of 81 secondary prevention patients.
• Algorithm involved high-intensity statin or statin-ezetimibe based on LDL-C and history.
• Treatment adherence and LDL-C levels tracked for one year.

Main Results:

• 63% initiated statin-ezetimibe; 37% started high-intensity statin.
• After one year, 70.4% adhered to initial treatment.
• Mean LDL-C was 49.5 mg/dL, with 63.2% reaching the <55 mg/dL target.

Conclusions:

• Early dual therapy (statin-ezetimibe) or high-intensity statin therapy can accelerate LDL-C target achievement.
• This strategy shows potential for improving outcomes in very high-risk cardiovascular patients.